Dealing with antimicrobial resistance - the Danish experience

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Standard

Dealing with antimicrobial resistance - the Danish experience. / Bager, Flemming; Aarestrup, Frank Møller; Wegener, Henrik Caspar.

I: Canadian Journal of Animal Science, Bind 80, Nr. 2, 2000, s. 223-228.

Publikation: Bidrag til tidsskriftTidsskriftartikelfagfællebedømt

Harvard

Bager, F, Aarestrup, FM & Wegener, HC 2000, 'Dealing with antimicrobial resistance - the Danish experience', Canadian Journal of Animal Science, bind 80, nr. 2, s. 223-228.

APA

Bager, F., Aarestrup, F. M., & Wegener, H. C. (2000). Dealing with antimicrobial resistance - the Danish experience. Canadian Journal of Animal Science, 80(2), 223-228.

Vancouver

Bager F, Aarestrup FM, Wegener HC. Dealing with antimicrobial resistance - the Danish experience. Canadian Journal of Animal Science. 2000;80(2):223-228.

Author

Bager, Flemming ; Aarestrup, Frank Møller ; Wegener, Henrik Caspar. / Dealing with antimicrobial resistance - the Danish experience. I: Canadian Journal of Animal Science. 2000 ; Bind 80, Nr. 2. s. 223-228.

Bibtex

@article{2883bf712332446187760d4480dcedba,
title = "Dealing with antimicrobial resistance - the Danish experience",
abstract = "Following the discovery in 1994 and 1995 that use of the glycopeptide antimicrobial avoparcin for growth promotion was associated with the occurrence of vancomycin resistant Enterococcus faecium in food animals and in food, the Danish Minister of Food, Agriculture and Fisheries banned the use of avoparcin in May 1995. The ban was later extended by the European Commission to include all EU member states. In May 1999, the EU Scientific Steering Committee recommended that use for growth promotion of antimicrobials, which are or may be used in human or veterinary medicine should be phased out as soon as possible and ultimately abolished. During the first half of the 1990s the consumption of tetracyclines, mainly in pig production, increased markedly. This was countered by severely reducing through legal means the financial enticement for veterinarians to prescribe medicines and by restricting the availability of tetracycline as non-registered speciality products. The focus on consumption of antimicrobials and on resistance prompted a number of initiatives by Danish authorities to limit the increase in antimicrobial resistance. One such initiative was the implementation of an integrated programme (DANMAP), which monitors resistance among bacteria from food animals, food and humans. A programme to monitor all use of prescription medicine in food animals at the herd level is presently being implemented. Another initiative was the elaboration of a series of practical recommendations to veterinarians on the prudent use of antimicrobials in order to reduce the development of resistance without compromising therapeutic efficacy. Our experience with avoparcin shows that a restrictive policy on the use of antimicrobials can curb the development of resistance. However, the occurrence and persistence of specific resistance phenotypes is the end-result of complex interactions of, among others, antimicrobial co-selection, clonal spread of resistant strains and Various herd management factors.",
author = "Flemming Bager and Aarestrup, {Frank M{\o}ller} and Wegener, {Henrik Caspar}",
year = "2000",
language = "English",
volume = "80",
pages = "223--228",
journal = "Canadian Journal of Animal Science",
issn = "0008-3984",
publisher = "Agricultural Institute of Canada",
number = "2",

}

RIS

TY - JOUR

T1 - Dealing with antimicrobial resistance - the Danish experience

AU - Bager, Flemming

AU - Aarestrup, Frank Møller

AU - Wegener, Henrik Caspar

PY - 2000

Y1 - 2000

N2 - Following the discovery in 1994 and 1995 that use of the glycopeptide antimicrobial avoparcin for growth promotion was associated with the occurrence of vancomycin resistant Enterococcus faecium in food animals and in food, the Danish Minister of Food, Agriculture and Fisheries banned the use of avoparcin in May 1995. The ban was later extended by the European Commission to include all EU member states. In May 1999, the EU Scientific Steering Committee recommended that use for growth promotion of antimicrobials, which are or may be used in human or veterinary medicine should be phased out as soon as possible and ultimately abolished. During the first half of the 1990s the consumption of tetracyclines, mainly in pig production, increased markedly. This was countered by severely reducing through legal means the financial enticement for veterinarians to prescribe medicines and by restricting the availability of tetracycline as non-registered speciality products. The focus on consumption of antimicrobials and on resistance prompted a number of initiatives by Danish authorities to limit the increase in antimicrobial resistance. One such initiative was the implementation of an integrated programme (DANMAP), which monitors resistance among bacteria from food animals, food and humans. A programme to monitor all use of prescription medicine in food animals at the herd level is presently being implemented. Another initiative was the elaboration of a series of practical recommendations to veterinarians on the prudent use of antimicrobials in order to reduce the development of resistance without compromising therapeutic efficacy. Our experience with avoparcin shows that a restrictive policy on the use of antimicrobials can curb the development of resistance. However, the occurrence and persistence of specific resistance phenotypes is the end-result of complex interactions of, among others, antimicrobial co-selection, clonal spread of resistant strains and Various herd management factors.

AB - Following the discovery in 1994 and 1995 that use of the glycopeptide antimicrobial avoparcin for growth promotion was associated with the occurrence of vancomycin resistant Enterococcus faecium in food animals and in food, the Danish Minister of Food, Agriculture and Fisheries banned the use of avoparcin in May 1995. The ban was later extended by the European Commission to include all EU member states. In May 1999, the EU Scientific Steering Committee recommended that use for growth promotion of antimicrobials, which are or may be used in human or veterinary medicine should be phased out as soon as possible and ultimately abolished. During the first half of the 1990s the consumption of tetracyclines, mainly in pig production, increased markedly. This was countered by severely reducing through legal means the financial enticement for veterinarians to prescribe medicines and by restricting the availability of tetracycline as non-registered speciality products. The focus on consumption of antimicrobials and on resistance prompted a number of initiatives by Danish authorities to limit the increase in antimicrobial resistance. One such initiative was the implementation of an integrated programme (DANMAP), which monitors resistance among bacteria from food animals, food and humans. A programme to monitor all use of prescription medicine in food animals at the herd level is presently being implemented. Another initiative was the elaboration of a series of practical recommendations to veterinarians on the prudent use of antimicrobials in order to reduce the development of resistance without compromising therapeutic efficacy. Our experience with avoparcin shows that a restrictive policy on the use of antimicrobials can curb the development of resistance. However, the occurrence and persistence of specific resistance phenotypes is the end-result of complex interactions of, among others, antimicrobial co-selection, clonal spread of resistant strains and Various herd management factors.

M3 - Journal article

VL - 80

SP - 223

EP - 228

JO - Canadian Journal of Animal Science

JF - Canadian Journal of Animal Science

SN - 0008-3984

IS - 2

ER -

ID: 172809733